Palvella Therapeutics, Inc.
PVLA
$23.44
-$1.13-4.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,037.44% | -- | -- | -54.21% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 1,059.60% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 1,068.97% | -- | -- | -- | |
|
|
|||||
| Total Current Assets | 1,068.97% | -- | -- | -- | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | 1,068.97% | -- | -- | -- | |
|
|
|||||
| Total Accounts Payable | 389.96% | -- | -- | -- | |
| Total Accrued Expenses | 241.43% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 1,773.96% | -- | -- | -- | |
| Total Other Current Liabilities | 1,773.96% | -- | -- | -- | |
| Total Current Liabilities | 410.08% | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | 410.08% | -- | -- | -- | |
| Long-Term Debt | 48.27% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 62.43% | -- | -- | -- | |
| Total Liabilities | 124.25% | -- | -- | -- | |
|
|
|||||
| Common Stock & APIC | 8,499.50% | -- | -- | -- | |
| Retained Earnings | -22.85% | -- | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 184.06% | -- | -- | 20.57% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 0.00% | |
|
|
|||||
| Total Common Equity | 184.06% | -- | -- | 20.57% | |
| Total Preferred Equity | -- | -- | -- | 0.00% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 1,713.58% | -- | -- | 83.26% | |
|
|
|||||